Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir vs Adefovir in Chronic Hepatitis B with Suboptimal Response
NCT00718887Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Bristol Myers Squibb. Started Jul 2008; status: completed.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00718887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00718887.